MedPath

Adding additive to spinal drug to see for pain relief after surgery

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/03/063780
Lead Sponsor
Ananya Krishna T
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All ASA1 and 2 patients undergoing elective lower abdominal surgery under subarachnoid block.

Exclusion Criteria

All ASA 3 and 4

Patients with spinal deformity

Pregnant patients

Patients with height less than 140cm

Patients with known drug allergy, preexisting cardiovascular, respiratory and neurological disorders

Patients with local skin infections, impaired liver or renal function tests, coagulation disorders

Patients with BMI more than 30kg/m2

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to assess onset and duration of sensory blockade, maximum sensory blockade and the time taken for it, time taken for 2 segment regression, onset and duration of motor blockade, total duration of postoperative analgesia.Timepoint: 1,2,3,4,5,10,15,20,25,30,35,40,45,50,55,60,65,70,75,80,85,90 minutes and till 3 hours postoperative period
Secondary Outcome Measures
NameTimeMethod
changes in heart rate, SBP,DBP,MAPTimepoint: 1, 1 1/2,2,21/2,3 hours
© Copyright 2025. All Rights Reserved by MedPath